This website is intended for healthcare professionals only.

Hospital Healthcare Europe
Hospital Pharmacy Europe     Newsletter          

Fighting a ‘winning’ battle against infection

The recent haemagglutinin type 1 and neuraminidase type 1 (H1N1) pandemic and the increased awareness on hospital-acquired infection (HAI) have stepped up the focus on infection control and the use of disinfectants.

Disinfectant offerings in the hand hygiene segment are particularly significant as they help prevent various hand-transmitted viruses such as methicillin-resistant staphylococcus aureus (MRSA), C difficile and norovirus.

New analysis from Frost & Sullivan finds that the market earned revenues of $440.1 million in 2009 and estimates this to reach $671.4 million in 2016.

The products covered in this research service are hand disinfectants, skin and mucous membrane disinfectants and instrument disinfectants.

 “The increased awareness on hand hygiene is driving the Western European disinfectant gels and scrubs market,” says Frost & Sullivan Research Analyst Beulah Devadason.

“Hand disinfection is the most important aspect of controlling HAI and doctors, nurses, and healthcare workers are required to adhere to hand hygiene practices in order to minimise the risk of infection and enhance patient safety.”

The use of alcohol-based hand rubs with 70 to 90 per cent alcohol provides adequate protection against most pathogens. However, spores such as C.difficile cannot be eradiated with alcohol. Therefore, there is a vital need to focus on technological innovation to improve efficacy of disinfectants in terms of the spectrum as well as time length of antimicrobial activity.

To find out more, please click on the link below:

Frost & Sullivan